000 03857nam a22004095i 4500
999 _c11487
_d11487
001 11487
003 DE-He213
005 20210713040333.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 180820s2018 si | s |||| 0|eng d
020 _a9789811310744
024 7 _a10.1007/978-981-13-1074-4
_2doi
040 _bspa
_dES-VaUE
050 4 _aRC826
_b.F86 2018 EB
245 1 0 _aFunctional Dyspepsia :
_bEvidences in Pathophysiology and Treatment
_cedited by Kazunari Tominaga, Hiroaki Kusunoki.
264 1 _aSingapore
_bSpringer Singapore :
_bImprint: Springer
_c2018.
300 _aVIII, 187 p. 61 illus., 46 illus. in color.
_bonline resource
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
490 _aMedicine (Springer-11650)
505 0 _aPART I: Etiology.-Chapter 1: Definition & Prevalence -- Chapter 2: Genetic Factor -- Chapter 3: Environmental Factors -- PART II: Pathophysiology -- Chapter 4: Neuro-gastroenterology: Central & Autonomic Nervous System.-Chapter 5: Neuro-gastroenterology: Enteric Nervous System -- Chapter 6: Neuro-gastroenterology: Esophago-gastric Function (Motility) .-Chapter 7: Neuro-Gastroenterology: Gastro-duodenal Function (Motility) and Ultrasonographic Assessment.-Chapter 8: Ghrelin and Functional Dyspepsia -- Chapter 9: Psycho-gastroenterology -- Chapter 10: Visceral Hypersensitivity Through Transient Receptor Potential Vanilloid 1 Channels (TRPV1) in Functional Dyspepsia.-PART III: Treatment.-Chapter 11: Efficacy of Acid Suppression Therapy.-Chapter 12: Prokinetics.-Chapter 13: Herbal Medicine.-PART IV: Recent Special Topics: Future Treatment Possibility -- Chapter 14: Gut Dysbiosis and Its Treatment in Patients with Functional Dyspepsia -- Chapter 15: Visceral Hypersensitivity in Functional Dyspepsia (FD) - Therapeutic Approaches to FD Based on Suppression of Visceral Hypersensitivity -- Chapter 16: Pancreatic Exocrine Function.
520 _aThe research and outcomes presented in this book gather evidence concerning both the pathogenesis and treatment of functional dyspepsia. It provides the latest information on this common non-organic disease, indicating its characteristic pathogenesis based on the brain-gut interaction and micro-environment and evidence gleaned from clinical treatment. Since the pathogenesis is associated with psychology, neurology, endocrinology and bacteriology in addition to gastroenterological physiology, it is often intractable and finding a suitable treatment rationale is challenging. Furthermore, the pathogenesis varies around the world and the efficacy of treatment using standard drugs varies among different populations worldwide; accordingly, this book highlights evidence gained in clinical trials in Japan. Functional Dyspepsia is a milestone produced by respected experts. Addressing unique topics and new findings of treatment including challenging and/or future rationales, it offers an invaluable resource for general clinicians, gastroenterologists, and basic researchers alike. .
653 0 _aGastroenterology.
653 0 _aMedicine, Psychosomatic.
653 0 _aEndocrinology.
700 1 _aTominaga, Kazunari.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aKusunoki, Hiroaki.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_9106996
776 0 8 _iPrinted edition:
_z9789811310737
776 0 8 _iPrinted edition:
_z9789811310751
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-13-1074-4
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db
_feng
_ggw
_h0